Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...
Abstract: A successive-approximation ADC with non-binary code achieves 55dB SNR at sampling frequencies up to 20MHz. The converter, with on-chip driver for analog input and reference input, measures 0 ...
Diffusion is a fantastically fun shooter, albeit with one big caveat.
The scientists working on the DNA cassette coated the partitions with a crystal shell made from a metal-organic framework, ...
On this Special Report, Geostrategist Brahma Chellaney analyses the significance of Russian President Vladimir Putin's visit to India, his first since the Ukraine war began. Chellaney argues that the ...
Converting a Traditional IRA to a Roth isn’t complicated once you’re clear on the taxes you’ll owe, but for anyone 60 or older, the upfront tax hit (and the bigger RMDs you’re trying to avoid) can ...
Abstract: Spiking neural networks (SNNs) have shown advantages in computation and energy efficiency over traditional artificial neural networks (ANNs) thanks to their event-driven representations.